75000 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 75010 - Statement - Statement of Assets and Liabilities (Unaudited) link:presentationLink link:calculationLink link:definitionLink 75020 - Statement - Statement of Assets and Liabilities (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 75030 - Statement - Statements of Operations and Incentive Allocation (Unaudited) link:presentationLink link:calculationLink link:definitionLink 75040 - Statement - Statements of Changes in Net Assets (Unaudited) link:presentationLink link:calculationLink link:definitionLink 75050 - Statement - Statement of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 75060 - Statement - Schedule of Investments (Unaudited) link:presentationLink link:calculationLink link:definitionLink 75060 - Statement - Schedule of Investments (Unaudited) [Default] link:presentationLink link:calculationLink link:definitionLink 75070 - Statement - Schedules of Investments (unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 995455 - Disclosure - Organization link:presentationLink link:calculationLink link:definitionLink 995465 - Disclosure - Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 995475 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 995485 - Disclosure - Investments link:presentationLink link:calculationLink link:definitionLink 995495 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 995505 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 995515 - Disclosure - Borrowings link:presentationLink link:calculationLink link:definitionLink 995525 - Disclosure - Net Assets link:presentationLink link:calculationLink link:definitionLink 995535 - Disclosure - Financial Highlights link:presentationLink link:calculationLink link:definitionLink 995545 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 995555 - Disclosure - Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 995565 - Disclosure - Investments (Tables) link:presentationLink link:calculationLink link:definitionLink 995575 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 995585 - Disclosure - Net Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 995595 - Disclosure - Financial Highlights (Tables) link:presentationLink link:calculationLink link:definitionLink 995605 - Disclosure - Organization (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995615 - Disclosure - Related Party Transactions (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995625 - Disclosure - Investments (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 995635 - Disclosure - Investments (Details) link:presentationLink link:calculationLink link:definitionLink 995645 - Disclosure - Investments (Details 1) link:presentationLink link:calculationLink link:definitionLink 995655 - Disclosure - Investments (Details 2) link:presentationLink link:calculationLink link:definitionLink 995665 - Disclosure - Investments (Details 3) link:presentationLink link:calculationLink link:definitionLink 995675 - Disclosure - Fair Value Measurements (Details) link:presentationLink link:calculationLink link:definitionLink 995685 - Disclosure - Fair Value Measurements (Details 1) link:presentationLink link:calculationLink link:definitionLink 995695 - Disclosure - Fair Value Measurements (Details 2) link:presentationLink link:calculationLink link:definitionLink 995705 - Disclosure - Commitments and Contingencies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995715 - Disclosure - Net Assets (Details) link:presentationLink link:calculationLink link:definitionLink 995725 - Disclosure - Net Assets (Details 1) link:presentationLink link:calculationLink link:definitionLink 995735 - Disclosure - Net Assets (Details 2) link:presentationLink link:calculationLink link:definitionLink 995745 - Disclosure - Net Assets (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 995755 - Disclosure - Financial Highlights (Details) link:presentationLink link:calculationLink link:definitionLink 995765 - Disclosure - Subsequent Events (Details Narrative) link:presentationLink link:calculationLink link:definitionLink Dividend and Interest Income Dividend and Interest Income Document Accounting Standard Borrowings Borrowings Pointivo Inc [Member] Impact to Valuation from an Increase in Input Impact to Valuation from an Increase in Input Commitments and contingencies (Note 6) Commitments and Contingencies Stock Repurchased During Period, Shares Shares purchased by investment adviser Minimum [Member] Minimum [Member] Document Registration Statement Investment Yield Percentage Investment Yield Percentage Fair Value, Recurring [Member] Fair Value, Recurring [Member] Management Fee, Description Management fee description Non-affiliated investments cost Non-affiliated investments cost Common stock, shares issued Common stock, shares issued Investment, Variable Interest Rate, Type [Extensible Enumeration] Investment, Variable Interest Rate, Type [Extensible Enumeration] Net Assets Disclosure Net Assets [Abstract] Istios Health, LLC [Member] Istios Health, LLC [Member] Istios Health, LLC [Member] Care Save Technologies Inc [Member] Counterparty Name [Domain] Incentive allocation attributable to the Investment Adviser IncentiveAllocationAttributableToInvestmentAdvisers Money Market Funds Percent Of Net Assets Money Market Funds Percent Of Net Assets Subsequent Event Type [Domain] Documents Incorporated by Reference [Text Block] Conversion of Convertible Note Interest to Preferred Stock Conversion of Convertible Note Interest to Preferred Stock Conversion of convertible note interest to preferred stock Maturity Date Maturity Date Schedule of Long-Term Debt Instruments [Table] Income Statement [Abstract] Restricted Investments, Percent of Net Assets Restricted Investments, Percent of Net Assets Investment Owned And Cost And Cash Equivalents Carrying Value Investment Owned And Cost And Cash Equivalents Carrying Value Acquisition Date Acquisition Date Distribution Made to Limited Partner, Cash Distributions Paid Distributions paid Schedule of investment portfolio at cost and fair value Schedule of investment portfolio at cost and fair value Investment Adviser [Member] From non-controlled / non-affiliated investments: Document Period End Date Expense Support and Conditional Reimbursement Agreement [Member] Debt Instrument [Line Items] Investment Owned, Balance, Shares Shares % of Net Assets Cash Equivalents Percent Of Net Assets Cash Equivalents Percent Of Net Assets Investment, Noncontrolled, Unaffiliated Issuer [Member] Investment, Noncontrolled, Unaffiliated Issuer [Member] Investment, non-controlled, non-affiliated investments Statement of Stockholders' Equity [Abstract] Schedule of Investments [Abstract] Document Shell Company Report Dividends Payable Dividend paid Dividend paid Entity Address, Country Net increase (decrease) in net assets resulting from operations Net increase (decrease) in net assets resulting from operations O2026 Q2 Dividends [Member] O2026 Q2 Dividends [Member] ChartSpan Medical Technologies, Inc. [Member] ChartSpan Medical Technologies, Inc. [Member] ChartSpan Medical Technologies, Inc. [Member] Dividends [Domain] Investments [Domain] Total assets Assets [Default Label] Title of 12(b) Security Distribution Payable Distribution declared during the period Distributions payable Preferred Stock Investments One [Member] Preferred Stock Investments [Member] No Trading Symbol Flag Net increase (decrease) in net assets attributable to common shareholders NetIncreaseDecreaseInNetAssetsAttributableToCommonShareholders Incentive Allocation attributable to the Investment Adviser Incentive Allocation attributable to the Investment Adviser Distributions paid (declared) to shareholders Measurement Input, Option Volatility [Member] Volatility Audited Annual Financial Statements Net investment income (loss) Investment Company, Investment Income (Loss), Per Share Cash and Cash Equivalents [Domain] Technology Enabled Marketplace [Member] Technology-Enabled Marketplace Other interest income Other interest income Investment Owned At Fair Value And Cash And Cash Equivalents Fair Value Disclosure Investment Owned At Fair Value And Cash And Cash Equivalents Fair Value Disclosure Investment, Issuer Affiliation [Domain] Incentive allocation attributable to the Investment Adviser IncentiveAllocationAttributableToInvestmentsAdviser Investment Owned At Cost And Money Market Funds Carrying Value Investment Owned At Cost And Money Market Funds Carrying Value Entity Address, Address Line Two Range (Weighted Average) Range (Weighted Average) Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Amortization of Deferred Loan Origination Fees, Net Amortization of deferred loan fees Amortization of deferred loan fees Management fees payable Management fee expenses Management fees payable Peregrine Health, Inc. [Member] Peregrine Health, Inc. [Member] Peregrine Health Inc . Member Interest Income, Other Interest earned Ratio of total expenses, excluding incentive fees Ratio of total expenses, excluding incentive fees Total expenses before Incentive Allocation Equity Investments [Member] Equity Investments Member Equity Investments [Member] Investment Owned, Balance, Principal Amount Par Amount Basis of Presentation Basis of Presentation Total increase, shares Total increase, shares Incentive Fee [Member] Incentive Fee Member Stock, Class of Stock [Table] Increase (decrease) in accrued expenses and other liabilities Increase (decrease) in accrued expenses and other liabilities Net assets Share Repurchase Program Description Share Repurchase Program Description Share repurchase program description Document Annual Report Portfolio turnover Portfolio turnover Schedule of investment unobservable inputs Schedule of investment unobservable inputs Statistical Measurement [Axis] Net change in unrealized gain (loss) on non-controlled / affiliated investments Net change in unrealized (gain) loss on non-controlled / affiliated investments Net Change In Unrealized Gain Loss On Noncontrolled Affiliated Investments Entity Interactive Data Current Investment Company [Abstract] Investment Company, Distribution to Shareholders, Per Share Distributions paid (declared) to shareholders Distributions paid (declared) to shareholders Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Common shares, par value $0.01 per share, unlimited shares authorized (3,477,477 and 3,161,369 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively) Common shares, par value $0.01 per share, unlimited shares authorized (4,917,011 and 4,364,449 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively) Entity Public Float Total liabilities Liabilities [Default Label] Schedule of fair value measurements Schedule of fair value measurements Product and Service [Axis] Investment Owned and Cash Equivalents Percent Of Net Assets Investment Owned and Cash Equivalents Percent Of Net Assets % of Net Assets Entity Bankruptcy Proceedings, Reporting Current Fair Value, Inputs, Level 3 [Member] Level 3 [Member] Cash and Cash Equivalents, Fair Value Disclosure Fair Value Total expenses Operating Expenses Share purchase price per share Share purchase price per share Net realized and unrealized gain (loss) Net realized and unrealized gain (loss) Organization Organization Fair Value Measurement Inputs and Valuation Techniques [Table] Shares issued price per share Shares issued price per share Issuance of common shares, shares Issuance of common shares, shares Increase (Decrease) in Prepaid Expense (Increase) decrease in prepaid expenses Restricted Investments, at Fair Value Fair Value of Restricted Securities Committed but not funded Committed bu not funded Committed but not funded Percentage of Total Investment Income Percentage of total investment income Net investment income (loss) before Incentive Allocation Incentive Allocation Attributable To The Investment Adviser [Member] Debt Investments [Member] Debt Investments Member Debt Investments [Member] Cash Equivalents [Member] Written Communications Related Party Transactions [Abstract] Long-Lived Asset, Class [Axis] Schedule of financial highlights Schedule of Financial Highlights Income Taxes Income Taxes Subsequent Events Subsequent Events Advanced expenses Advanced expenses Distributable Earnings Losses [Member] Other general and administrative expenses Other general and administrative expenses Fair Value Hierarchy and NAV [Axis] Short-Term Debt, Type [Axis] Payments For Purchases Of Investments Payments For Purchases Of Investments Payments for purchases of investments % of Net Assets Percentage of total assets % of Net Assets Prepaid expenses Prepaid Expense and Other Assets Gross Additions Gross Additions Total return after Incentive Fee and Incentive Allocation Total return before Incentive Fee and Incentive Allocation Total return after Incentive Allocation Total liabilities and net assets Liabilities and Equity Entity Voluntary Filers Offering price per share Offering price per share Document Fiscal Period Focus Net Assets NetAssetsTextBlock Net change in unrealized gain (loss) included in earnings related to financial instruments held as of september 30, 2023 Net change in unrealized gain (loss) included in earnings related to financial instruments Investment Owned And Money Market Funds Percent Of Net Assets Investment Owned And Money Market Funds Percent Of Net Assets Valuation Technique Valuation Technique Organizational expenses Organizational expenses Entity Current Reporting Status Use of Estimates Use of Estimates Fair Value, Inputs, Level 1 [Member] Level 1 [Member] Financial Highlights Financial Highlights Pre-commencement Tender Offer Investment Type [Axis] Other Reporting Standard Item Number Healthcare Health Care [Member] Interest income Interest income Proceeds from Deferred Loan Fees Proceeds from deferred loan fees Proceeds From Deferred Loan Fees Proceeds from deferred loan fees Document Transition Report Commitments and contingencies (Note 6) Commitments and Contingencies Disclosure [Abstract] Commitments and contingencies (Note 6) Gross Reductions Gross Reductions Gross Reductions Senior Secured Convertible Notes Two [Member] Fair Value Investment Owned and Cash Equivalents Fair Value Investment Owned and Cash Equivalents Fair Value Common Stock Investments [Member] Common Stock Investments [Member] Net increase (decrease) in net assets attributable to common shareholders Net increase (decrease) in net assets attributable to common shareholders Common Stock [Member] Investments Investment [Text Block] Statistical Measurement [Domain] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Senior Secured Convertible Notes One [Member] Senior Secured Convertible Notes [Member] Assets Entity Primary SIC Number Entity Central Index Key Total distributable earnings (loss) Total distributable earnings (losses) Current Fiscal Year End Date Document Quarterly Report Entity Address, Address Line Three Conversion of convertible notes to preferred stock Conversion Of Convertible Notes To Preferred Stock Conversion Of Convertible Notes To Preferred Stock Valuation of Investments Valuation of Investments Cash and Cash Equivalents [Axis] Fair Value, Inputs, Level 2 [Member] Level 2 [Member] Total investment income Investment Income, Net Net change in unrealized gain (loss) on investments Net change in unrealized (gain) loss on non-controlled Net change in unrealized gain (loss) on investments ShiftMed's Preferred SeriesE-2 [Member] ShiftMed's Preferred SeriesE-2 [Member] ShiftMed's preferred Series E-2 [Member] Net cash provided by (used in) operating activities Net Cash Provided by (Used in) Operating Activities Entity Incorporation, State or Country Code Sale of stock Sale of stock Schedule of Net Asset Value Per Share Schedule of Net Asset Value Per Share Total investments cost Total investments cost Net realized and unrealized gain (loss) on investments: Commitments and Contingencies Commitments And Contingencies Long-Lived Asset, Class [Domain] Share Repurchase Program, Authorized, Number of Shares Number of shares repurchase Administration fees Administration fees Title of 12(g) Security Incentive allocation attributable to the Investment Adviser Incentive allocation attributable to the Investment Adviser Affiliated investments cost Affiliated investments cost Measurement Frequency [Domain] Equity Components [Axis] Total return before Incentive Fee and Incentive Allocation Total return before Incentive Fee and Incentive Allocation Total return before Incentive Allocation Gain (Loss) on Investments Gain (Loss) on Investments, Total Net realized and unrealized gain (loss) on investments Statement of Cash Flows [Abstract] Fair Value Hierarchy and NAV [Domain] Net investment income (loss) Net investment income (loss) Incentive Allocation Incentive Allocation Revenue Recognition Revenue Recognition Schedule of Investments [Line Items] Integrative Life Network, LLC [Member] Fair Value Measurements Fair Value Measurements Increase (decrease) in incentive fees payable Increase (decrease) in incentive fees payable Pre-commencement Issuer Tender Offer Management fees Management fee Interest Rate Total Interest Rate Money Market Funds Par Amount Money Market Funds Par Amount Investments Soliciting Material Counterparty Name [Axis] Measurement Input, Expected Term [Member] Term Segment Reporting Segment Reporting Interest receivable Interest receivable Subscriptions [Member] Short-Term Debt [Line Items] Short-Term Debt [Table] Measurement Input, Discount Rate [Member] Discount rate Payment for Incentive Fee Investments, All Other Investments [Abstract] Increase Decrease In Receivable From Sale Of Investments Increase Decrease In Receivable From Sale Of Investments (Increase) decrease in receivable from sale of investments (Increase) decrease in receivable from sale of investments Net asset value per share attributable to common shareholders Net asset value, beginning of period Net asset value, end of period Net asset value per share Price per share Security Reporting Obligation Document Type Cash and cash equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Cash flows from operating activities: Dividends Payable [Table] Change in Unrealized Gains (Losses) Change in Unrealized Gains (Losses) Subsequent Event [Member] Subsequent Event [Member] Sale of Stock, Price Per Share Price per share (Increase) decrease in interest receivable Increase (Decrease) in Finance Receivables O2026 Q1 Dividends [Member] O2026 Q1 Dividends [Member] O2026 Q1 Dividends [Member] Stock Redeemed or Called During Period, Value Aggregate purchase price Entity File Number Investment, Issuer Affiliation [Axis] Investment Owned At Fair Value And Money Market Funds Fair Value Investment Owned At Fair Value And Money Market Funds Fair Value Accrued expenses and other liabilities Accrued expenses and other liabilities Korio Inc [Member] Net change in unrealized gain (loss) on non-controlled / non-affiliated investments Net change in unrealized (gain) loss on non-controlled / non-affiliated investments Net Change In Unrealized Gain Loss On Noncontrolled Nonaffiliated Investments Convertible Notes [Member] Convertible Notes [Member] Convertible Notes [Member] Dividends Payable, Date of Record Dividend record date Dividend record date Net increase (decrease) in net assets resulting from operations NetIncreaseDecreaseInNetAssetResultingFromOperations Entity Registrant Name Accounting Policies [Abstract] Net assets, end of period Net assets Beginning balance, shares Ending balance, shares Partners' Capital Account, Units Range (Weighted Average) Years Range (Weighted Average) Years Entity Address, Address Line One Extension O2025 Q3 Dividends [Member] O2025 Q3 dividends member. Dividend Payable Date October 16, 2025 [Member] Fair Value, Recurring and Nonrecurring [Table] Statement Of Assets And Liabilities Unaudited Supplemental Cash Flow Information [Abstract] Supplemental Disclosure of Cash-Flow Information Class of Stock Disclosures [Abstract] Estimated time to exit (in years) Measurement Input, Estimated Exit [Member] Measurement Input, Estimated Exit [Member] Related Party Transactions Related Party Transactions Entity Small Business Net Realized Gain or Loss and Net Change in Unrealized Gain or Loss Net Realized Gain or Loss and Net Change in Unrealized Gain or Loss Proceeds from deferred loan fees Loan Processing Fee Proceeds from deferred loan fees MediaFly, Inc. [Member] Total Investments [Member] Long-Term Debt, Type [Axis] Schedule of Dividends Payable [Table Text Block] Shedule of Dividend Declaration Significant Accounting Policies Increase (Decrease) in Accrued Taxes Payable Increase (Decrease) in Accrued Taxes Payable, Total Increase (decrease) in accrued audit and tax fees Investments [Member] Changes in operating assets and liabilities: Enterprise SaaS [Member] Enterprise SaaS Board of Trustees’ fees Board of Trustees' fees Kythera Labs [Member] Entity Well-known Seasoned Issuer Ratio of total expenses to average net assets Ratio of total expenses to average net assets Ratio of total expenses to average net assets Net investment income (loss) after Incentive Allocation Subsequent Event Type [Axis] Product and Service [Domain] Country Region Measurement Frequency [Axis] Cash flows from financing activities: Investment, Affiliated Issuer, Noncontrolled [Member] Investment, Noncontrolled, affiliated Issuer [Member] Non Controlled/Affiliated Investments [Member] Incentive allocation recorded Incentive allocation recorded Senior Secured Convertible Note [Member] Senior Secured Convertible Note Member Senior Secured Convertible Notes [Member] Investment Non Issuer Noncontrolled [Member] Schedule of Net Assets Schedule of Net Assets Liabilities Preferred Stock Investments [Member] Preferred Stock Investments [Member] Entity Tax Identification Number Schedule of transactions related to investments Schedule of transactions related to investments Equity Component [Domain] Entity Address, City or Town Measurement Input Type [Domain] Issuance of common shares Issuance of common shares Entity Common Stock, Shares Outstanding Total net assets Partners' Capital Beginning balance, value Ending balance, value Schedule of aggregate percentage of total assets or investment income Schedule of aggregate percentage of total assets or investment income Dividends Payable [Line Items] Entity [Domain] Unsecured Convertible Notes [Member] Unsecured Convertible Notes [Member] Unsecured Convertible Notes [Member] Statement [Table] Incentive fees Incentive fee Amendment Description Entity Shell Company Statement [Line Items] O2025 Q2 Dividends [Member] O2025 Q2 Dividends [Member] Dividend Payable Date July 16, 2025 [Member] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Non-controlled / non-affiliated equity investments [Member] Investment, Unaffiliated Issuer [Member] Maximum [Member] Maximum [Member] Money Market Funds At Fair Value Money Market Funds At Fair Value Debt Disclosure [Abstract] Cost Cost Total increase Total increase Net Assets Attributable To Common Shareholders [Member] Unobservable Input Unobservable Input Junior Secured Convertible Notes [Member] Junior Secured Convertible Notes [Member] Junior Secured Convertible Notes [Member] Net change in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Document Period Start Date Subsequent Events [Abstract] Investment Total investments after cash equivalents Investment amount Shares issued and sold, amount Shares issued and sold, amount Dividends Payable, Amount Per Share Dividend paid per share Dividend paid per share Dividends Payable, Nature Type Document Fiscal Year Focus Common stock, shares outstanding Common stock, shares outstanding Collaborative Arrangement and Arrangement Other than Collaborative [Table] Care Save Technologies [Member] Measurement Input, Revenue Multiple [Member] Revenue Multiples Elected Not To Use the Extended Transition Period Accrued audit and tax fees Accrued audit and tax fees Transaction price Measurement Input, Transaction price [Member] Measurement Input, Transaction price [Member] Security Exchange Name Measurement Input Type [Axis] Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Warrant [Member] Warrant [Member] Organization and Offering Costs Organization and Offering Costs Entity Address, State or Province Incentive fees payable Incentive fee payable Incentive fees payable Amendment Flag Net Investment Income (Loss) Net Investment Income (Loss) Net investment income (loss) Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents City Area Code Organization, Consolidation and Presentation of Financial Statements [Abstract] Proceeds from issuance of common shares Proceeds from issuance of common shares Investment, Identifier [Axis] Schedule of unrealized gain loss on investment Schedule of unrealized gain loss on investment Schedule of Investments [Table] Preferred Stock Investments Two [Member] Expenses: Net increase (decrease), shares Net increase (decrease), shares Dividends Payable, Date to be Paid Dividend payable date Software Tools [Member] Software Tools Total expenses after Incentive Fee and Incentive Allocation Total expenses after Incentive Fee and Incentive Allocation Total expenses after Incentive Allocation Preferred Stock Investments Four [Member] Preferred Stock Investments Four Member Common stock, par value Common stock, par value Legal Entity [Axis] Receivable, Investment, Sale Receivable from sale of investments O 2026 Q3 Dividends [Member] O2026 Q3 Dividends [Member] Distributions declared to shareholders Distribution Made to Limited Partner, Cash Distributions Declared Distributions declared to shareholders Distributions declared during the period % of Total Investments at Fair Value % of Total Investments at Fair Value Percentage Of Total Investments At Fair Value Total Schedule of investments at fair value Schedule of investments at fair value Short-Term Debt, Type [Domain] Net increase (decrease) in net assets resulting from operations NetIncreaseDecreaseInNetAssetsResultingFromOperations Net Increase Decrease In Net Assets Resulting From Operations Net increase (decrease) in net assets resulting from operations Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Trading Symbol Preferred Stock Investments Three [Member] Preferred Stock Investments Three [Member] Preferred Stock Investments Three [Member] Entity Emerging Growth Company Dividends Payable, Date Declared Dividend declaration date Additional Paid-in Capital [Member] Dividends [Axis] Money market treasury fund Money market treasury fund Cash Equivalents Fair Value Disclosure Cash Equivalents Fair Value Disclosure Cash Equivalents, FairValue Document Shell Company Event Date Annual Information Form Cover [Abstract] Net assets attributable to common shareholders NetAssetsAttributableToCommonShareholders Preferred Equity Investments [Member] Investment Owned at Cost And Cash Equivalents Carrying Value Investment Owned at Cost And Cash Equivalents Carrying Value Cost Purchases of investments Purchases of investments Investment income: Long-Term Debt, Type [Domain] Professional fees Professional fees Healthcare I T [Member] Healthcare Offering costs Offering Cost, Expense Paid-in-capital in excess of par value Paid-in-capital in excess of par value Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities: Fair Value Disclosures [Abstract] Cash and cash equivalents Cash and cash equivalents Increase (decrease) in management fees payable Increase (decrease) in management fees payable Net cash provided by (used in) financing activities Net Cash Provided by (Used in) Financing Activities First American Treasury Obligations Fund [Member] First American Treasury Obligations Fund Member First American Treasury Obligations Fund [Member] Net increase (decrease), amount Net increase (decrease), amount Interest rate Interest rate Cash Equivalents, at Carrying Value Cash Equivalents, at Carrying Value, Total Cash Equivalents, Cost Entity Filer Category Fair Value Total investments before cash equivalents Fair Value Fair value, beginning of period Fair value, end of period Junior Secured Convertible Note [Member] Junior Secured Convertible Note [Member] Junior Secured Convertible Note [Member] Number of Shares outstanding at end of period Number of Shares outstanding at end of period Peregrine Health, Inc. [Member] Peregrine Health, Inc. [Member] [Default Label] Entity Address, Postal Zip Code Statement of Financial Position [Abstract] Local Phone Number